To qualify for Mounjaro, you typically need a diagnosis of type 2 diabetes or, for off-label weight loss use, a BMI of 30 or higher (or 27 or higher with a weight-related health condition). Beyond the medical criteria, the bigger hurdle for most people is insurance coverage, which often requires prior authorization and proof that you’ve tried cheaper medications first.
The FDA-Approved Qualification: Type 2 Diabetes
Mounjaro (tirzepatide) is FDA-approved specifically to improve blood sugar control in adults and children 10 and older with type 2 diabetes, used alongside diet and exercise. If your doctor has diagnosed you with type 2 diabetes, you meet the core medical requirement. The FDA label doesn’t set a minimum A1C level or fasting glucose threshold for eligibility. A confirmed type 2 diabetes diagnosis is what matters.
This is the most straightforward path to getting Mounjaro prescribed and covered by insurance. Weight loss, while a common and significant effect of the medication, is not the approved use for this specific drug.
Qualifying for Weight Loss Without Diabetes
Doctors can prescribe Mounjaro off-label for weight loss even if you don’t have type 2 diabetes. The same active ingredient, tirzepatide, is sold under a different brand name (Zepbound) that’s specifically approved for weight management. When providers prescribe Mounjaro off-label for weight loss, they generally follow the same BMI thresholds used for other GLP-1 weight loss medications:
- BMI of 30 or higher with no additional conditions required
- BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, high cholesterol, sleep apnea, prediabetes, or fatty liver disease
There’s an important catch here. Most insurance plans will not cover Mounjaro for weight loss, since it isn’t FDA-approved for that purpose. Cigna’s coverage policy, for example, explicitly lists weight loss as a condition not covered under Mounjaro. If you’re seeking tirzepatide for weight management, your doctor would typically prescribe Zepbound instead, and your insurer would evaluate that claim under its obesity coverage policies. You can’t swap the two brands to game the system. Insurers expect you to use the version approved for your specific condition.
What Insurance Requires Beyond a Diagnosis
Having a qualifying diagnosis gets you a prescription, but it doesn’t guarantee your insurance will pay for it. Most plans require prior authorization for Mounjaro, meaning your doctor’s office has to submit paperwork proving you meet the plan’s criteria before the pharmacy will fill it at the covered price.
The most common insurance requirement is step therapy. This means you need to have tried at least one lower-cost diabetes medication, usually metformin, before the plan will approve Mounjaro. Some insurers check automatically: if you’ve filled a metformin prescription within the past 130 to 180 days, the Mounjaro claim processes without extra steps. If you haven’t, the claim gets rejected and your doctor needs to submit a prior authorization explaining why. Valid reasons include an inadequate response to metformin, intolerance (like significant digestive side effects), or a medical contraindication that prevents you from taking it.
Approval periods vary by insurer but are commonly granted for one year at a time, after which your doctor may need to reauthorize.
Medicare Coverage Criteria
Medicare has its own qualification tiers for GLP-1 medications under its bridge program, and they’re stricter than what private insurers or prescribing doctors typically require. The thresholds depend on your BMI and which health conditions you have:
- BMI of 35 or higher: qualifies with no additional diagnosis needed
- BMI of 30 or higher: qualifies with heart failure with preserved ejection fraction, uncontrolled high blood pressure (despite already taking two blood pressure medications), or chronic kidney disease stage 3a or above
- BMI of 27 or higher: qualifies with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease
All Medicare applicants must be at least 18. Your provider submits a prior authorization request attesting that you meet these criteria.
Medical Conditions That Disqualify You
Certain medical histories make Mounjaro off-limits regardless of your diabetes status or BMI. You cannot take Mounjaro if you or anyone in your family has had medullary thyroid carcinoma, a specific type of thyroid cancer. You’re also disqualified if you have Multiple Endocrine Neoplasia syndrome type 2, a genetic condition that affects hormone-producing glands. These are the only absolute contraindications listed on the drug’s label.
Your doctor will also evaluate whether Mounjaro is appropriate alongside your other medications and health conditions. People with a history of pancreatitis, severe gastrointestinal disease, or certain other conditions may need closer monitoring or a different medication entirely.
The Practical Steps to Get Started
The process typically works like this: you see your primary care doctor, endocrinologist, or an obesity medicine specialist. They confirm your diagnosis (type 2 diabetes or, for off-label use, your BMI and any qualifying conditions), review your medication history, and check for contraindications. If you meet the criteria, they write the prescription and submit a prior authorization to your insurance.
If you’ve never taken metformin or another first-line diabetes medication, expect your insurer to require that step first. This doesn’t mean you’ll be stuck on metformin indefinitely. If it doesn’t control your blood sugar adequately after a reasonable trial, or if you can’t tolerate it, your doctor documents that and resubmits for Mounjaro approval.
For people paying out of pocket without insurance, the medical qualification is simpler since there’s no prior authorization process. You need a prescription from a licensed provider who determines the medication is appropriate for you. The cost without coverage, however, runs over $1,000 per month, which is why most people work through their insurance even when the approval process takes extra time.